Lv3
260 积分 2021-02-18 加入
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
6天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
1个月前
已完结
[Expert consensus on the diagnosis and treatment of advanced non-small cell lung cancer with EGFR PACC mutations (2025 edition)]
1个月前
已完结
CONCORDANCE
1个月前
已完结
[Expert consensus on Claudin18.2 expression testing in gastric cancer (2025 version)]
3个月前
已完结
[Expert consensus on combined DNA and RNA next-generation sequencing of common driver genes in solid tumors (2025 version)]
5个月前
已完结
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
5个月前
已完结
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
5个月前
已完结
皖公网安备34019202002308
